Frequent amplification of 8q24, 11q, 17q, and 20q‐specific genes in pancreatic cancer
暂无分享,去创建一个
Mattias Höglund | Anne Kallioniemi | M. Höglund | A. Kallioniemi | M. Bärlund | M. Tanner | L. Gorunova | R. Karhu | E. Mahlamäki | Maarit Bärlund | Eija H. Mahlamäki | Minna Tanner | Ludmila Gorunova | Ritva Karhu
[1] A. Andrén-sandberg,et al. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer , 1999, Genes, chromosomes & cancer.
[2] S. Gansauge,et al. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. , 1997, Cancer research.
[3] T. Furuya,et al. A Comparison of DNA Copy Number Changes Detected by Comparative Genomic Hybridization in Malignancies of the Liver, Biliary Tract and Pancreas , 2001, Oncology.
[4] W. Kuo,et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. , 1994, Cancer research.
[5] D. Altieri,et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.
[6] S. Knuutila,et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.
[7] A. Chott,et al. Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspects. , 1998, British Journal of Cancer.
[8] A. Andrén-sandberg,et al. Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations , 1998, Genes, chromosomes & cancer.
[9] N. Arens,et al. Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH) , 2000, The Journal of pathology.
[10] R. Kuick,et al. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. , 1998, Genomics.
[11] F. Waldman,et al. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma , 1997, Genes, chromosomes & cancer.
[12] P. Meltzer,et al. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. , 1999, The American journal of pathology.
[13] B Johansson,et al. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer , 1997, Genes, chromosomes & cancer.
[14] Michael L. Bittner,et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Moskaluk,et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. , 1997, Cancer research.
[16] W. Kuo,et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.
[17] Y. Geng,et al. Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.
[18] J Piper,et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.
[19] A. Abioye,et al. Pancreatic carcinoma. , 2020, Journal of the National Medical Association.
[20] G. Capellá,et al. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma. , 2000, Cancer genetics and cytogenetics.
[21] P. Lichter,et al. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. , 1996, Cancer research.
[22] D. Iannitti,et al. Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma , 2001, American journal of clinical oncology.